Expression of fibroblast growth factor binding protein in head and neck cancer

Archives of Otolaryngology - Head and Neck Surgery

Volumn 135, Issue 9, 2009, Pages 896-901

  Li, Weimin ^a   Wang, Chuan ^a   Juhn, Steven K ^a   Ondrey, Frank G ^a   Lin, Jizhen ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Lions Research Bldg ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIBODY; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; METASTASIS; MICROVASCULATURE; PROTEIN BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; CARCINOMA, SQUAMOUS CELL; CARRIER PROTEINS; CASE-CONTROL STUDIES; FEMALE; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM STAGING; PROBABILITY; PROGNOSIS; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 70349331489     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archoto.2009.121     Document Type: Article

References (23)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin. 1996;46(1):5-27.
2. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1(1):27-31.
3. Czubayko F, Smith RV, Chung HC, Wellstein A. Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J Biol Chem. 1994;269(45):28243-28248. (Pubitemid 24354563)
4. Czubayko F, Liaudet-Coopman ED, Aigner A, Tuveson AT, Berchem GJ, Wellstein A. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer. Nat Med. 1997;3(10):1137-1140. (Pubitemid 27444457)
5. Berking C, Takemoto R, Satyamoorthy K, Elenitsas R, Herlyn M. Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin. Am J Pathol. 2001;158(3):943-953. (Pubitemid 32221786)
6. Wu DQ, Kan MK, Sato GH, Okamoto T, Sato JD. Characterization and molecular cloning of a putative binding protein for heparin-binding growth factors. J Biol Chem. 1991;266(25):16778-16785. (Pubitemid 21907866)
7. Gospodarowicz D, Neufeld G, Schweigerer L. Fibroblast growth factor. Mol Cell Endocrinol. 1986;46(3):187-204.
8. Klagsbrun M, Moses MA. Molecular angiogenesis. Chem Biol. 1999;6(8):R217-R224.
9. Kurtz A, Wang HL, Darwiche N, Harris V, Wellstein A. Expression of a binding protein for FGF is associated with epithelial development and skin carcinogenesis. Oncogene. 1997;14(22):2671-2681. (Pubitemid 27283106)
10. Rak J, Kerbel RS. bFGF and tumor angiogenesis-back in the limelight? Nat Med. 1997;3(10):1083-1084. (Pubitemid 27444445)
11. Cherukuri DP, Goulet AC, Inoue H, Nelson MA. Selenomethionine regulates cyclooxygenase-2 (COX-2) expression through nuclear factor-kappa B (NF-kappaB) in colon cancer cells. Cancer Biol Ther. 2005;4(2):175-180. (Pubitemid 41351315)
12. Lin J, Ozeki M, Javel E, et al. Identification of gene expression profiles in rat ears with cDNA microarrays. Hear Res. 2003;175(1-2):2-13. (Pubitemid 36870674)
13. Lin J, Tsuboi Y, Pan W, Giebink GS, Adams GL, Kim Y. Analysis by cDNA microarrays of altered gene expression in middle ears of rats following pneumococcal infection. Int J Pediatr Otorhinolaryngol. 2002;65(3):203-211. (Pubitemid 35292054)
14. Lin J, Tsuboi Y, Rimell F, et al. Expression of mucins in mucoid otitis media. J Assoc Res Otolaryngol. 2003;4(3):384-393. (Pubitemid 37187817)
15. Tanigawa N, Matsumura M, Amaya H, et al. Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer. 1997; 79(2):220-225. (Pubitemid 27029885)
16. Nakopoulou L, Lekkas N, Lazaris AC, et al. An immunohistochemical analysis of angiogenesis in invasive breast cancer with correlations to clinicopathologic predictors. Anticancer Res. 1999;19(5C):4547-4553. (Pubitemid 30042823)
17. Yoshida A, Anand-Apte B, Zetter BR. Differential endothelial migration and proliferation to basic fibroblast growth factor and vascular endothelial growth factor. Growth Factors. 1996;13(1-2):57-64. (Pubitemid 26193743)
18. Beatrice F, Cammarota R, Giordano C, et al. Angiogenesis: prognostic significance in laryngeal cancer. Anticancer Res. 1998;18(6B):4737-4740. (Pubitemid 29042053)
19. Inoue K, Ozeki Y, Suganuma T, Sugiura Y, Tanaka S. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma: association with angiogenesis and tumor progression. Cancer. 1997;79(2):206-213. (Pubitemid 27029883)
20. Dray TG, Hardin NJ, Sofferman RA. Angiogenesis as a prognostic marker in early head and neck cancer. Ann Otol Rhinol Laryngol. 1995;104(9, pt 1):724-729.
21. Dellacono FR, Spiro J, Eisma R, Kreutzer D. Expression of basic fibroblast growth factor and its receptors by head and neck squamous carcinoma tumor and vascular endothelial cells. Am J Surg. 1997;174(5):540-544. (Pubitemid 27486022)
22. Petruzzelli GJ, Benefield J, Taitz AD, et al. Heparin-binding growth factor(s) derived from head and neck squamous cell carcinomas induce endothelial cell proliferations. Head Neck. 1997;19(7):576-582. (Pubitemid 27407311)
23. Steenfos HH. Growth factors and wound healing. Scand J Plast Reconstr Surg Hand Surg. 1994;28(2):95-105.